1 |
Lamprecht, S. A. and M. Lipkin. 2003. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat. Rev. Cancer. 3, 601-613.
DOI
ScienceOn
|
2 |
Sung, J. J., J. Y. Lau, K. L. Goh and W. K. Leung. 2005. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 6, 871-876.
DOI
ScienceOn
|
3 |
Woo, K. J., T. J. Lee, S. H. Lee, J. M. Lee, J. H. Seo, Y. J. Jeong, J. W. Park and T. K. Kwon, 2007. Elevated gadd153/chop expression during resveratrol-induced apoptosis in human colon cancer cells. Biochem. Pharmacol. 73, 68-76.
DOI
ScienceOn
|
4 |
Wilson, L. C., S. J. Baek, A. Call and T. E. Eling. 2003. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int. J. Cancer 105, 747-753.
DOI
ScienceOn
|
5 |
Ricchi, P., R. Zarrilli, A. di Palma and A. M. Acquaviva. 2003. Non-steroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy. Br. J. Cancer 88, 803-807.
DOI
ScienceOn
|
6 |
Richter, M., M. Weiss, I. Weinberger, G. Furstenberger and B. Malian. 2001. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis 22, 17-25.
DOI
ScienceOn
|
7 |
Surh, Y. J. 2003. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3, 768-780.
DOI
ScienceOn
|
8 |
Thompson, H. J., C. Jiang, J. Lu, R. G. Mehta, G. A. Piazza, N. S. Paranka, R. Pamukcu and D. J. Ahnen, 1997. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res. 57, 267-271
|
9 |
Williams, C. S., A. P. Goldman, H. Sheng, J. D. Morrow and R. N. DuBois, 1999. Sulindac sulfide, but not sulindac sulfone, inhibits colurectal cancer growth. Neoplasia 1, 170-176.
DOI
ScienceOn
|
10 |
Giovannucci, E., E. B. Rimm, M. J. Stampfer, G. A. Colditz, A. Ascherio and W. C. Willett. 1994. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med. 121, 241-246.
DOI
ScienceOn
|
11 |
Greenlee, R. T., T. Murray, S. Bolden and P. A. Wingo. 2000. Cancer statistics, 2000. CA Cancer J. Clin. 50, 7-33.
DOI
ScienceOn
|
12 |
Lee, S. H., K. Yamaguchi, J. S. Kim, T. E. Eling, S. Safe, Y. Park and S. J. Baek. 2006. Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis 27, 972-981.
DOI
ScienceOn
|
13 |
Harris, R. E., J. Beebe-Donk and G. A. Alshafie. 2007. Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study. Int. J. Biol. Sci. 3, 328-334.
|
14 |
Hong, W. K. and M. B. Sporn. 1997. Recent advances in chemoprevention of cancer. Science 278, 1073-1077.
DOI
ScienceOn
|
15 |
Jarvis, M. C, T. J. Gray and C. N. Palmer. 2005. Both PP ARgamma and PP ARdelta influence sulindac sulfide-mediated p21WAF/CIP1 upregulation in a human prostate epithelial cell line. Oncogene 24, 8211-8215.
DOI
|
16 |
Liu, X., S. J. Plummer, N. L. Nock, G. Casey and J. S. Witte. 2006. Nonsteroidal antiinflmmatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha. Am. J. Epidemiol. 164, 984-989.
DOI
ScienceOn
|
17 |
Matsumoto, M., M. Minami, K. Takeda, Y. Sakao and S. Akira. 1996. Ectopic expression of CHOP (GADD153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett. 395, 143-147.
DOI
ScienceOn
|
18 |
Parkin, D. M., S. L. Whelan, J. Ferlay, L. Teppo and D. B. Tomas. 2003. Cancer incidence in five continents. Vol 8. Lyon, France. International Agency for Research on Cancer.
|
19 |
Rahme, E., J. Ghosn, K. Dasgupta, R. Rajan and M. Hudson. 2005. Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer. BMC Cancer 5, 159.
DOI
|
20 |
Baek, S. J., J. S. Kim, S. M. Moore, S. H. Lee, J. Martinez and T. E. Eling. 2005. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol. Pharmacol. 67, 356-364.
DOI
ScienceOn
|
21 |
Baek, S. J., R. Okazaki, S. H. Lee, J. Martinez, J. S. Kim, K. Yamaguchi, Y. Mishina, D. W. Martin, A. Shoieb, M. F. McEntee and T. E. Eling. 2006. Nonsteroidal anti-inflmmatory drug-activated gene-lover expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 131, 1553-1560.
DOI
ScienceOn
|
22 |
Barnes, A. P., B. E. MilIer and G. L. Kucera. 2007. Cyclooxygenase inhibition and hyperthermia for the potentiation of the cytotoxic response in ovarian cancer cells. Gynecol. Oncol. 104, 443-450.
DOI
ScienceOn
|
23 |
Barone, M. V., A. Crozat, A. Tabaee, L. Philipson and D. Ron. 1994. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev. 8, 453 - 464.
DOI
ScienceOn
|